Joseph Todisco - 23 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Executive Officer, Director
Signature: /s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol: CRMD
Transactions as of: 23 Jan 2026
Net transactions value: -$198,515
Form type: 4
Filing time: 27 Jan 2026, 21:30:29 UTC
Previous filing: 20 Jan 2026
Next filing: 06 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Todisco Joseph	Chief Executive Officer, Director	C/O CORMEDIX INC.,, 389 INTERPACE PKWY, SUITE 450, PARSIPPANY	/s/ Beth Zelnick Kaufman, attorney-in-fact	27 Jan 2026	0001774807

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+225,900	+45%	$0.000000	724,899	23 Jan 2026	Direct	F1
transaction	CRMD	Common Stock	Tax liability	$198,515	-27,306	-3.8%	$7.27	697,593	23 Jan 2026	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Content

These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.